Why the study?
The year 2023 saw numerous new publications in cardiology and revised ESC guidelines on ACS, endocarditis, heart failure, and cardiovascular prevention, prompting a summary of the most significant updates.
Design
Review article
Highlights evolving ESC standards for ACS, endocarditis, and HF; leaves open prospective validation of revised pathways.
The year 2023 has been extremely rich in new publications in the various subfields of cardiology. Furthermore, the European Society of Cardiology (ESC) has issued revised guidelines focused on the management of acute coronary syndrome (ACS) and endocarditis, as well as an update on the recommendations for the management of heart failure and cardiovascular prevention. The most significant updates according to the Cardiology Department of CHUV are summarized in this review article.
No takes yet. Share an insight, caveat, or question.
Salihu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: